- Staat
- IN
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 11.10.2022
- Impfdatum
- 15.09.2022
- Beginn
- 19.09.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrospinal fluid leakage
Craniotomy
Intensive care
Iron deficiency anaemia
Lumbar puncture
Magnetic resonance imaging head abnormal
Meningitis haemophilus
Red blood cell transfusion
Seizure
Symptomtext
H. Flu meningitis - PICU hospitalization -Spinal tap - IV antibiotics - ceftriaxone Seizures - Keppra Subdural fluid collection -MRI Burr Hole drilled - Hospital Iron Deficiency anemia - Packed RBC transfusion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 14,0
- Labordaten
- Spinal Tap MRI
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 26.05.2022
- Impfdatum
- 25.02.2022
- Beginn
- 26.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bacterial test
Blood culture negative
CSF glucose normal
CSF protein normal
CSF red blood cell count positive
CSF white blood cell count negative
Chest X-ray normal
Computerised tomogram head normal
Electroencephalogram abnormal
Full blood count
Haemoglobin decreased
Lumbar puncture
Lymphocyte percentage
Neutrophil percentage
Nitrite urine absent
Platelet count increased
Red blood cells urine positive
SARS-CoV-2 test negative
Symptomtext
Patient reported to have seizure episode for 10 minutes. Seen at ED and then transferred to hospital and had CT, LP , labs and EEG completed. Required versed to resolve seizure episode. Since then has been evaluated in ED and hospital due to multiple episodes of seizure activity.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- 2,0
- Labordaten
- CBC ( 2/26/2022)--WBC of 13.8, HgB 9.3, Plt 517, 55% N, 35% L no bands UA (2/26/2022)--with negative leuks and nitrites, few bacteria, 2-5 RBC LP- (2/26/2022)--WBC 1, RBC 1, glucose 55, protein 31 Blood Culture-negative COVID ( 2/26/2022): negative CT (2/26/2022)IMPRESSION: No evidence of acute intracranial hemorrhage, significant intracranial mass effect, or displaced calvarial fracture. If there is clinical concern for an underlying seizure focus, MR brain imaging would be recommended for further characterization. CXR- (2/26/2022)-normal
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- No previous history.
- Andere Medikamente
- Give 1 dose of acetaminophen after vaccines.
- Allergien
- No known allergies prior to vaccines given.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 01.06.2023
- Impfdatum
- 03.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Post vaccination fever
Symptomtext
Postvaccination fever on 2022-06-07.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Post vaccination fever
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Encounter for routine child health examination NOS
- Vorgeschichte
- -
- Andere Medikamente
- ACETAMINOPHEN 160 MG/5ML ORAL SOLN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 28.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash erythematous
Symptomtext
Developed four red spots on forehead and on one cheek- not raised, noted after giving vaccines, No distress, exam normal except noted above baby was given Benadryl, Rash resolved within a few minutes. Observed here for 30 minutes awake no distress or rash at discharge
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Right Side Nasal Congestion
- Vorgeschichte
- Alpha Thalassemia, BW 2000-2500grams, Preemie 35wks
- Andere Medikamente
- Formula Neosure
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- M
- Eingang
- 21.04.2022
- Impfdatum
- 21.04.2022
- Beginn
- 21.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash erythematous
Symptomtext
Developed four red spots on forehead and one on cheek- not raised, noted after giving vaccines. NO distress, exam normal, except for noted above, Baby was given Benadryl. Rash resolved within a few minutes. Observed for 30 minutes awake and no distress or rash before discharged.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Righ Side Nasal Congestion
- Vorgeschichte
- Alpha Thalassemia, Birth Weight 2000-2500grams, Preemie 35wks
- Andere Medikamente
- Formula: Neosure
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 07.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Pyrexia
Symptomtext
Patient reports fever. The adverse event was that Pfizer was not diluted and patient was administered non diluted Pfizer. Mother informed and follow up revealed a fever today, will treat, no other major adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- NKA
- Aktuelle Erkrankungen
- NKA
- Vorgeschichte
- NKA
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,4
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Diarrhoea
Pyrexia
Rash erythematous
Respiration abnormal
Urticaria
Symptomtext
103 fever and urticaria, given tylenol for infants At 8am 02/18/2022 had 'hives' on back, stomach, and arms; red spots; unknown if itchy Seems resolved now Breathing 'looked a little funny yesterday'-no wheezing 'or anything like that' but later mom said she seemed like trying to catch her breath but breathing fine Diarrhea on 02/17/2022 after vaccines
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Acute URI of multiple sites.
- Vorgeschichte
- None.
- Andere Medikamente
- Vitamin D3.
- Allergien
- Dairy.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 24.11.2023
- Impfdatum
- 14.11.2023
- Beginn
- 14.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Administration of an expired Infanrix dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 2-month-old male patient who received DTPa (Infanrix) (batch number 5N259, expiry date 05-OCT-2023) for prophylaxis. On 14-NOV-2023, the patient received Infanrix. On 14-NOV-2023, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Administration of an expired Infanrix dose). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-Nov-2023 The reporter reported that the 2 month old patient received an expired dose of Infanrix vaccine, which led to which led to expired vaccine used. The reporter wanted to know if the dose was considered valid. The reporter did consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 24.10.2023
- Impfdatum
- 13.10.2023
- Beginn
- 13.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
expired drug used; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 9-week-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 5N259, expiry date 05-OCT-2023) for prophylaxis. On 13-OCT-2023, the patient received Pediarix. On 13-OCT-2023, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: expired drug used). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-OCT-2023 The registered nurse reported that an expired dose of Pediarix was administered to a patient which led to expired vaccine used. The reporter to consented to follow up. The vaccine administration facility is the same as primary reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 26.05.2023
- Impfdatum
- 08.05.2023
- Beginn
- 08.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Symptomtext
Vaccine given SQ instead of IM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,2
- Geschlecht
- U
- Eingang
- 06.04.2023
- Impfdatum
- 13.02.2023
- Beginn
- 13.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
Symptomtext
Pediarix and Engerix given on the same day; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 2-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number 5N259) for prophylaxis. Co-suspect products included HBV (Engerix B) (batch number FB9RH) for prophylaxis. On 13-FEB-2023, the patient received Pediarix and Engerix B. On 13-FEB-2023, an unknown time after receiving Pediarix and Engerix B, the patient experienced accidental overdose (Verbatim: Pediarix and Engerix given on the same day). The outcome of the accidental overdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-MAR-2023 The reporter was a medical assistant. The reporter consented to follow up. The patient received Engerix B and Pediarix on same day, which led to overdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 31.03.2023
- Impfdatum
- 23.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Adverse reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-03-25.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Adverse reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Iron deficiency anemia, unspecified; Overweight; Elevated blood-pressure reading, without diagnosis of hypertension; Encounter for routine child health examination NOS; Immunization not carried out for unspecified reason
- Vorgeschichte
- -
- Andere Medikamente
- CETIRIZINE HCL 1 MG/ML ORAL SOLN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 22.09.2022
- Impfdatum
- 12.08.2022
- Beginn
- 12.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Administration site nodule
Symptomtext
Patient received routine vaccines as above. Mom noted a few days later a small subcutaneous nodule in right thigh at administration site that has persisted at her 4 month visit
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Administration site nodule
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- nystagmu
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- -
- Geschlecht
- F
- Eingang
- 14.06.2022
- Impfdatum
- 25.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Patient was seen 3 weeks prior for routine vaccinations which she received. Patient had another visit in which the same routine vaccines were pended, ordered and given again by RN. Inapproporate interval of vaccines given too close together which will require the patient to be revaccinated again at the proper interval. Vaccines- Dtap, Hep B, Polio, Prevnar 13, Hib, Rotavirus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Vaccination received 3 weeks too soon on 3/25/22. Received Dtap, Hep B, Polio, Prevnar 13, Hib, and Rotavirus and will require revaccination
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 27.05.2022
- Impfdatum
- 17.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patient was administrated with Pediarix an extra dose of Sanofi IPV; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 3-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 5n259, expiry date 5th October 2023) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and POLIOMYELITIS VACCINE INACTIVATED (IPV VACCINE) for prophylaxis. On 17th May 2022, the patient received the 1st dose of Pediarix, Pediarix Pre-Filled Syringe Device and IPV VACCINE. On 17th May 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-May-2022 Reporter's comments: Medical assistance reported that the patient was administrated with Pediarix and an extra dose of Sanofi IPV vaccine on same day. No adverse event was reported. The vaccine administration facility was the same as primary reporter. The consent to follow up was given. Additional Supportive Information: The patient received Pediarix and an extra dose of Sanofi IPV vaccine on same day, which led to overdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 20.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient's date of birth was entered incorrected upon being registered in the computer. Patient was brought in for newborn check and was administered vaccines appropriate for a 2 month old child due to the date of birth being incorrect. At this time, patient has no side effects reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 30.03.2022
- Impfdatum
- 30.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
None in office
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/a
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 22.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Extra dose given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 22.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
administered a fourth dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 9-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 5N259, expiry date 5th October 2023) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Pediarix (received 1st dose on 25 August 2021), Pediarix (received 2nd dose on 20th October 2021) and pediatrix (received 3rd dose on 16th December 2021). On 9th March 2022, the patient received the 1st dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 9th March 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received Pediarix series and the patient was then inadvertently administered a fourth dose which led to extra dose administered. The reporter consented to follow up. The health care professional gave permission for follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 05.03.2022
- Beginn
- 05.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 16.03.2022
- Impfdatum
- 15.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Drug dispensed to wrong patient
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Doctor circle the wrong vaccines in chart and medical assistant administered them to the wrong patient that was meant for the younger sibling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Drug dispensed to wrong patient
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 0,1
- Geschlecht
- M
- Eingang
- 16.03.2022
- Impfdatum
- 28.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Eye swelling
Stridor
Symptomtext
Swollen eyes, ? stridor the following morning after vaccine administration. Resolved spontaneously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye swelling
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Reflux/Spitting up; mainly physiologic
- Andere Medikamente
- Vit D drops
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 10.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Vaccine administered experienced a low temperature excursion and data did not support it' s use. Patient has not reported adverse reaction. Revaccination plan being organized.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product storage error
Symptomtext
Vaccine administered was exposed to low temperatures and is considered an invalid dose. Patient has not reported negative reactions. Revaccination plan is being planned.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Vaccine administered was exposed to a low temperature and not supported for administration. Patient has not reported any reactions. Revaccination plan to be initiated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- N/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Vaccine administered was exposed to a low temperature and not supported for administration. Patient has not reported any reactions. Revaccination plan to be initiated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 1,3
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Vaccine administered was exposed to a low temperature and not supported for administration. Patient has not reported any reactions. Revaccination plan to be initiated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Vaccine administered was exposed to a low temperature and not supported for administration. Patient has not reported any reactions. Revaccination plan to be initiated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
10 year old was administered PEDIARIX; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 5N259, expiry date 5th October 2023) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 17th February 2022, the patient received Pediarix (intramuscular) .5 ml and Pediarix Pre-Filled Syringe Device. On 17th February 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received Pediarix in left deltoid. The patient received Pediarix at the age of 10 years, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient did not had symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- N/A
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 11.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
Engerix-B - Pediarix administered on same day; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 6-month-old male patient who received HBV (Engerix B pediatric) (batch number 2H575, expiry date 12th September 2022) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number 5N259, expiry date 5th October 2023) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 2nd February 2022, the patient received Engerix B pediatric, Pediarix and Pediarix Pre-Filled Syringe Device. On 2nd February 2022, unknown after receiving Engerix B pediatric, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The reporter was a nurse. The patient received a dose of Engerix B and Pediarix on the same day, which led to overdose of hepatitis B vaccine. Consent to follow up was granted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
This patient came in on 01.19.2022 to see Dr. and got her second dose of primary vaccines (Pediarix - DTaP, hep B, IPV, hib, PCV, and flu). First dose of primary vaccines was given at 6mo0days on 12.03.2021. The CDC recommends if the vaccine was given more than four days before the recommended minimum due date (01.28.22 per system), then you will repeat dosage at the recommended interval. I spoke with MDs for their recommendations as pediatricians in clinic. Dr. believes that this is not a true error, as children receive an extra hep B dosage with the normal intervals. Due to this patient being late to receiving the first primary dose of vaccines, this is what is equating the "error". Also, the human body can tolerate an additional hep B vaccine dose. Dr. stated that due to patient needing to come in within the next four weeks for their second flu shot, that when they come in for that they could get the next series dosage. This needs to happen AFTER February 19th. After the date February 19th, this patient can receive her second flu shot, third pediarix dosage, third PCV, and third HIB. This patient has an appointment on February 18th where doctor has okayed the patient to receive her next dose at that appointment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 0,6
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Underdose
Symptomtext
did not received the full dose, partial dose was administered; 7 months old was administered Pediarix; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 7-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number 5N259, expiry date 5th October 2023) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Pediarix (received 1st and 2nd dose on an unknown date). On 28th January 2022, the patient received the 3rd dose of Pediarix (intramuscular) and Pediarix Pre-Filled Syringe Device. On 28th January 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the underdose and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: Reporter was a nurse manager at the health care facility. The nurse reported that, the patient did not receive the full dose of their Pediarix injection, which led to underdose. The partial dose that was administered was the 3rd dose in the Pediarix series and was administered into the right thigh. The nurse also reported the seven months old patient received dose of Pediarix, which led to inappropriate age at vaccine administration. The reporter consented to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 0,6
- Geschlecht
- M
- Eingang
- 31.01.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
No adverse events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Ear infection
- Vorgeschichte
- N/A
- Andere Medikamente
- Famotidine and Cefdinir
- Allergien
- N/A
- Vorherige Impfungen
- -